Insider Transactions in Q1 2023 at Liquidia Corp (LQDA)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 28
2023
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+2.45%
|
-
|
Feb 28
2023
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,171
-2.1%
|
$15,197
$7.56 P/Share
|
Feb 28
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+6.78%
|
-
|
Feb 28
2023
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+5.11%
|
-
|
Feb 28
2023
|
Robert A Lippe Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,033
-1.07%
|
$14,231
$7.56 P/Share
|
Feb 28
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+3.48%
|
-
|
Jan 11
2023
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
104,167
+22.36%
|
-
|
Jan 11
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+47.22%
|
-
|
Jan 11
2023
|
Roger Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
289,500
+36.82%
|
-
|
Jan 11
2023
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
124,667
+43.41%
|
-
|
Jan 11
2023
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+31.99%
|
-
|
Jan 11
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+31.48%
|
-
|
Jan 03
2023
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,807
+7.09%
|
-
|